Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Potent, topically active glucocorticoid from RPR shows potential for bronchial asthma

Oct. 24, 1997

Abbott develops inhibitors of LT biosynthesis

Oct. 24, 1997

TBC-1269 enters phase II for treatment and prevention of asthma

Oct. 24, 1997

Oxis Turbuhaler launched in U.K.

Oct. 23, 1997

Bradykinin antagonists from Pfizer

Oct. 23, 1997

FDA approves RPR's Nasacort for pediatric use

Oct. 20, 1997

Switch OTCs for allergies to be introduced by Fujisawa

Oct. 17, 1997

Toxicity studies reported for new expectorant from SS Pharm.

Oct. 17, 1997

Byk Gulden describes new agents for asthma

Oct. 17, 1997

CRP-derived peptides for chronic inflammatory disorders developed at Yeda

Oct. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...